Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Dr.Reddy's Laboratories Ltd Announces Launch Of Finasteride Tablets


Wednesday, 2 Jan 2013 11:39pm EST 

Dr. Reddy's announced that it has launched Finasteride Tablets (1 mg), a bioequivalent generic version of Propecia (Finasteride) Tablets in the US market on January 2, 2013. Dr.Reddy's ANDA for Finasteride 1 mg Tablets has been awarded a 180-day period of marketing exclusivity in the U.S. on January 2, 2013. 

Company Quote

48.83
0.8 +1.67%
17 Oct 2014